- Dr. Herbert H. Loong holds conjoint appointments as Clinical Associate Professor in the Department of Clinical Oncology and Deputy Medical Director ofthe Phase 1 Clinical Trials Centre at The Chinese University of Hong Kong.
- Obtained his medical degree with a Distinction in Surgery from The University of Hong Kong in 2003.
- Completed a Fellowship in Drug Development at Princess Margaret Cancer Centre, Toronto, Canada, focusing on Experimental Therapeutics.
- Clinical and research interests: Thoracic Oncology, Sarcoma Medical Oncology, Health Economics.
- Awards and recognitions:
- European Cancer Congress Fellowship Grant (2013)
- ASCO Annual Meeting Merit Award (2014)
- Hong Kong College of Physicians Young Investigators’ Award (2014)
- Fellow of the American Society of Clinical Oncology (2024)
- Led the CUHK Lung Cancer Team to receive the IASLC Foundation Cancer Care Team Award (2018) for best thoracic oncology care in “Asia & Rest ofthe World”.
- Co-founded the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC).
- Serves or has served in multiple roles in international oncology organizations:
- International Affairs Committee and Asia-Pacific Regional Council of ASCO
- Membership, Education and Communications Committees of IASLC
- Chairman of the International Affairs Committee of ASCO for 2024–2025
- Board Member of the Connective Tissue Oncology Society (CTOS, 2022–2024)
- Former member of the Pharmacy and Poisons Board of Hong Kong, overseeing registration of medicinal products and clinical trials in the territory.
